Abstract
Introduction
Pain after surgical extraction of third molars has been a nemesis for oral surgeons with clinicians, thus striving for an analgesic modality. NSAIDs are among the most widely used therapeutic classes of analgesics. Transbuccal diclofenac sodium patches have been developed as an innovative drug delivery system using buccal mucosa as a gifted choice, hence overcoming first pass metabolism and offering the advantage of sustained drug delivery with reduced incidence of systemic adverse effects.
Aim
A comparative study was conducted to evaluate the efficacy of diclofenac sodium for pain control, administered via the far-fetched and gifted novel route through the transbuccal patch and by ever popular per oral route and also to assess the adverse effects vis-à-vis for transbuccal diclofenac patch and oral diclofenac following extraction of bilaterally symmetrical impacted mandibular third molars under local anaesthesia.
Methodology
Thirty healthy subjects of both the sexes in the age of 12 to 50 years with asymptomatic bilaterally symmetrical mandibular third molars underwent extraction under LA. It is a split-mouth study, i.e. after the extraction of tooth on one side, diclofenac sodium (50 mg) via oral route was given and then in another visit, when the same patient is comfortable and asymptomatic, extraction on contralateral side was executed and transbuccal patched diclofenac sodium (20 mg) was applied. Pain was measured on visual analog scale and verbal rating scale by the patient for 3 days and adverse effects if any were noted.
Result
Statistical analysis showed that transbuccal diclofenac sodium was significantly efficacious when compared to the drug administered orally. Also, statistically significant results were obtained in percentage reduction in pain from 1st to 3rd postoperative day in transbuccal group. No significant difference is seen for adverse reactions.
Conclusion
Transbuccal diclofenac sodium patch is more efficacious and can be used for pain control.
Similar content being viewed by others
Abbreviations
- TBDP:
-
Transbuccal diclofenac patch
- VAS:
-
Visual analog scale
- VRS:
-
Verbal rating scale
- NSAISs:
-
Non-steroidal anti-inflammatory drugs
- HPMC:
-
Hydroxypropyl methylcellulose
References
Susarla MS, Dodson TD (2004) Risk factors for third molar extraction difficulty. J Oral Maxillofac Surg 62:1363–1371
Desjardins PJ, Grossman EH, Kuss ME, Talwalker S, Dhadda S, Baum D, Hubbard RC (2001) The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively. Anesth Analg 93:721–727
Baichali PS, Nandakumar H (2009) Comparative study of diclofenac transdermal patch against oral diclofenac for pain control following removal of mandibular impacted third molars. J Oral Maxillofac Surg 8(2):167–172
Cooper SA, Beaver WT (1976) A model to evaluate mild analgesics in oral surgery out patients. Clin Pharmacol Ther 20:241
The royal college of anaesthetics. Guidelines for the use of Non steroidal anti-inflamatory drugs in the perioperative period. March 1998
Heyneman CA, Lawless-Liday C, Wall GC (2000) Oral versus topical NSAIDs in rheumatic diseases. A Comparison. Drugs 60:555–574
Dhikav V, Singh S, Pande S, Chawla A, Anand KS (2003) Non-steroidal drug-induced gastrointestinal toxicity: mechanism and management. J Indian Acad Clin Med 4(4):315–322
Naesdal J, Brown K (2006) NSAIDs associated adverse effects and acid control aids to prevent them a review of current treatment options. Drugs Saf 29:119–132
Roth SH, Shainhouse JZ (2004) Efficacy and safety of topical diclofenac sodium (Pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle controlled clinical trial. Arch Intern Med 164:2017–2023
Doshi A, Koliyote S, Joshi B (2011) Design and evaluation of buccal film of diclofenac sodium. Int J Pharm Biol Sci 1(1):17–30
Predel HG, Kroll R, Pabst H, Dieter R, Gallacchi G, Gianetti B et al (2004) Diclofenac patch for topical treatment of acute impact injuries: a randomized, double blind, placebo controlled, multicentre study. Br J Sports Med 38:318–323
Cranny A, O’Donneil S (2005) Topical diclofenac improved pain and physical functions with no systemic side effects in primary osteoarthritis of the knee. Evid Based Med 10:81
Radbruch L (2003) Buprenorphin TDS used in daily practice, benefits for patients. Int J Clin Pract Suppl 133:19–22
Khan AB, Mahamana R, Pal E (2014) Review on mucoadhesive drug delivery system: novel approach in modern era. J Pharm Sci 4(4):128–141
Shugars DA, Benson K, White RP, Simpson KN, Bader JD (1996) Developing a measure of patient perceptions of short-term outcomes of third molar surgery. J Oral Maxillofac Surg 54(12):1402–1408
Wolfe MM, Lichtenstein DR, Singh G (1999) Gastrointestinal toxicity of non steroidal anti inflammatory drugs. New Engl J Med 340:1888–1899
Doomra R, Gupta SK (2001) Intensive adverse drug reaction monitoring in various specialty clinics of a tertiary care hospital in North India. Int J Med Toxicol 4(1):1–4
Simon LS, Weaver AL, Graham DY (1999) Anti-inflamatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA 282(20):1921–1928
Tolman KG (1998) Hepatotoxicity of non-narcotic analgesics. Am J Med 105(1B):13S–19S
Kappus H (1986) Overview of enzyme systems involved in bioreduction of drugs and in redox cycling. Biochem Pharm 35:1–6
Uyemura SA, Santos AC, Mingatto FE, Jordani MC, Curti C (1997) Diclofenac sodium and mefenamic acid: potent inducers of the membrane permeability transition in renal cortex mitochondria. Arch Biochem Biophys 342(2):231–235
Susarla MS, Blaeser BF (2003) Third molar surgery and associated complications. Oral Maxillofac Surg Clin North Am 15:177–186
Varghese KG (2010) A practical guide to the management of impacted teeth,1st ed, p136
Acknowledgements
We would like to show our gratitude to Sudha Rustagi College of Dental Sciences and Research, Faridabad, for sharing its pearls of wisdom with us during the course of this research. We are also immensely grateful to Dr K R Indushekhar, Member secretary, Institutional Ethical Committee, who provided insight and expertise that greatly assisted the study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors Dr. Kartikeya Sharma, Dr. Pallavi Sharma, Dr. Ashish Gupta, Dr. Pankaj Bansal and Dr. Shivprasad Behera declare that they have no conflict of interest.
Ethical Approval
All procedures performed in the study involving human participants were in accordance with the ethical standards approved by the Member Secretary, Institutional Ethical Committee, Sudha Rustagi College of Dental Sciences and Research, Faridabad, affiliated to Pt. B.D. Sharma University of Health and Sciences, Rohtak, which is recognized by the Dental Council of India and Ministry of Health and Family Welfare, Govt. of India.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Sharma, K., Sharma, P., Gupta, A. et al. Pain Control by Novel Route of Gifted Choice Against Peroral Route. J. Maxillofac. Oral Surg. 18, 339–344 (2019). https://doi.org/10.1007/s12663-017-1001-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12663-017-1001-3